Skip to main content
Erschienen in: Journal of Cancer Education 1/2013

01.03.2013

Evaluation of a Method to Improve the Consent Process: Improved Data Retention with Stagnant Comprehension

verfasst von: Pranitha Naini, James Lewis, Kothanur Rajanna, Alva Bowen Weir III

Erschienen in: Journal of Cancer Education | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Our study explored whether a simple, cost-effective intervention directed only at physicians could improve patient comprehension with informed consent process. In our medical university oncology clinic, we performed a baseline survey on 69 patients receiving new therapy, testing for comprehension of the important components of the informed consent process. We then instituted a three-part intervention, including (1) physician education, (2) an available toxicity list, and (3) a checklist to ensure physician compliance. We repeated the survey on 54 consecutive patients who consented for treatment, evaluating four outcomes. The intervention produced a 38 % improvement in patients' listing of toxicities (p = 0.0003) and no significant improvements in the understanding of therapeutic goals, likelihood of achieving those goals, and confidence in their understanding of treatment. Our three-part intervention, directed solely at physicians, improved patients' recall of toxicity data but did not influence the other important areas of patient comprehension within the informed consent process.
Literatur
1.
Zurück zum Zitat Treleaven J, Cullis JO, Maynard R et al (2005) Obtaining consent for chemotherapy. BJH 132:552–559CrossRef Treleaven J, Cullis JO, Maynard R et al (2005) Obtaining consent for chemotherapy. BJH 132:552–559CrossRef
2.
Zurück zum Zitat Guimond P, Bunn H, O’Connor AM et al (2003) Validation of a tool to assess health practitioners’ decision support and communication skills. Patient Educ Couns 50:235–245PubMedCrossRef Guimond P, Bunn H, O’Connor AM et al (2003) Validation of a tool to assess health practitioners’ decision support and communication skills. Patient Educ Couns 50:235–245PubMedCrossRef
3.
Zurück zum Zitat Elwyn G, Hutchings H, Edwards A et al (2005) The OPTION scale: measuring the extent the clinicians involve patients in decision-making tasks. Health Expect 8:34–42PubMedCrossRef Elwyn G, Hutchings H, Edwards A et al (2005) The OPTION scale: measuring the extent the clinicians involve patients in decision-making tasks. Health Expect 8:34–42PubMedCrossRef
4.
Zurück zum Zitat Stevenson FA, Cox K, Britten N, Dundar Y (2004) A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 7:235–245PubMedCrossRef Stevenson FA, Cox K, Britten N, Dundar Y (2004) A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 7:235–245PubMedCrossRef
5.
Zurück zum Zitat Temel JS, Greer JA, Admane S et al (2011) Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 29:2319–2326PubMedCrossRef Temel JS, Greer JA, Admane S et al (2011) Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 29:2319–2326PubMedCrossRef
6.
Zurück zum Zitat Figg WD, Smith EK, Price DK et al (2010) Disclosing a diagnosis of cancer: where and how does it occur? J Clin Oncol 28:3630–3635PubMedCrossRef Figg WD, Smith EK, Price DK et al (2010) Disclosing a diagnosis of cancer: where and how does it occur? J Clin Oncol 28:3630–3635PubMedCrossRef
7.
Zurück zum Zitat Dodd MJ, Mood DW (1981) Chemotherapy: helping patients to know the drugs they are receiving and their possible side effects. Cancer Nurse 4:311–318CrossRef Dodd MJ, Mood DW (1981) Chemotherapy: helping patients to know the drugs they are receiving and their possible side effects. Cancer Nurse 4:311–318CrossRef
8.
Zurück zum Zitat Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W (1999) Informed decision making in outpatient practice: time to get back to basics. JAMA 24:2313–2320CrossRef Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W (1999) Informed decision making in outpatient practice: time to get back to basics. JAMA 24:2313–2320CrossRef
9.
Zurück zum Zitat Audrey S, Abel J, Blazeby JM, Falk S, Campbell R (2008) What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study. BMJ 337:1–9CrossRef Audrey S, Abel J, Blazeby JM, Falk S, Campbell R (2008) What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study. BMJ 337:1–9CrossRef
10.
Zurück zum Zitat Olver IN, Turrell SJ, Olszewski NA, Willson KJ (1995) Impact of an information and consent form on patients having chemotherapy. Med J Aust 162:82–83PubMed Olver IN, Turrell SJ, Olszewski NA, Willson KJ (1995) Impact of an information and consent form on patients having chemotherapy. Med J Aust 162:82–83PubMed
11.
Zurück zum Zitat Weeks JC, Catalano PJ, Cronin A et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. NEJM 367:1616–1625PubMedCrossRef Weeks JC, Catalano PJ, Cronin A et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. NEJM 367:1616–1625PubMedCrossRef
12.
Zurück zum Zitat Leighl NB, Shepherd HL, Butow PN et al (2011) Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy. J Clin Oncol 29:2077–2084PubMedCrossRef Leighl NB, Shepherd HL, Butow PN et al (2011) Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy. J Clin Oncol 29:2077–2084PubMedCrossRef
13.
Zurück zum Zitat O’Connor AM, Bennett C, Stacey D et al (2007) Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making 27(5):554–575PubMedCrossRef O’Connor AM, Bennett C, Stacey D et al (2007) Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making 27(5):554–575PubMedCrossRef
14.
Zurück zum Zitat Tulsky JA, Arnold RM, Alexander SC et al (2011) Enhancing communication between oncologists and patients with a computer-based training program. Ann Intern Med 155:593–601PubMed Tulsky JA, Arnold RM, Alexander SC et al (2011) Enhancing communication between oncologists and patients with a computer-based training program. Ann Intern Med 155:593–601PubMed
15.
Zurück zum Zitat Back AL, Arnold RM, Baile WF et al (2007) Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167:453–460PubMedCrossRef Back AL, Arnold RM, Baile WF et al (2007) Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167:453–460PubMedCrossRef
16.
Zurück zum Zitat Alexander SC, Keitz SA, Sloane R et al (2006) A controlled trial of a short course to improve residents’ communication with patients at the end of life. Acad Med 81:1008–1012PubMedCrossRef Alexander SC, Keitz SA, Sloane R et al (2006) A controlled trial of a short course to improve residents’ communication with patients at the end of life. Acad Med 81:1008–1012PubMedCrossRef
17.
Zurück zum Zitat Butow P, Cockburn J, Girgis A, CUES Team et al (2008) Increasing oncologists’ skills in eliciting and responding to emotional cues: evaluation of a communication skills training program. Psych Oncol 17:209–218CrossRef Butow P, Cockburn J, Girgis A, CUES Team et al (2008) Increasing oncologists’ skills in eliciting and responding to emotional cues: evaluation of a communication skills training program. Psych Oncol 17:209–218CrossRef
18.
Zurück zum Zitat Kissane DW, Bylund CL, Banerjee SC et al (2012) Communication skills training for oncology professionals. J Clin Oncol 30:1242–1247PubMedCrossRef Kissane DW, Bylund CL, Banerjee SC et al (2012) Communication skills training for oncology professionals. J Clin Oncol 30:1242–1247PubMedCrossRef
19.
Zurück zum Zitat Houts PS, Doak CC, Doak LG, Loscalzo MJ (2006) The role of pictures in improving health communication: a review of research on attention, comprehension, recall and adherence. Patient Educ Couns 61:173–190PubMedCrossRef Houts PS, Doak CC, Doak LG, Loscalzo MJ (2006) The role of pictures in improving health communication: a review of research on attention, comprehension, recall and adherence. Patient Educ Couns 61:173–190PubMedCrossRef
20.
Zurück zum Zitat Jones CL, Byrne DJ, Rice P, Cuschieri A (1993) Factors affecting quality of informed consent. BMJ 306:885–890CrossRef Jones CL, Byrne DJ, Rice P, Cuschieri A (1993) Factors affecting quality of informed consent. BMJ 306:885–890CrossRef
21.
Zurück zum Zitat Cassileth BR, Zupkis RV, Sutton-Smith K, March V (1980) Informed consent—why are its goals imperfectly realized? N Engl J Med 302:896–900PubMedCrossRef Cassileth BR, Zupkis RV, Sutton-Smith K, March V (1980) Informed consent—why are its goals imperfectly realized? N Engl J Med 302:896–900PubMedCrossRef
22.
Zurück zum Zitat Muss HB, White DR, Michielutte R et al (1979) Written informed consent in patients with breast cancer. Cancer 43:1549–1556PubMedCrossRef Muss HB, White DR, Michielutte R et al (1979) Written informed consent in patients with breast cancer. Cancer 43:1549–1556PubMedCrossRef
23.
Zurück zum Zitat Bergler JH, Pennington AC, Metcalfe M, Freis ED (1980) Informed consent: how much does the patient understand? Clin Pharmacol Ther 27:435–440PubMedCrossRef Bergler JH, Pennington AC, Metcalfe M, Freis ED (1980) Informed consent: how much does the patient understand? Clin Pharmacol Ther 27:435–440PubMedCrossRef
24.
Zurück zum Zitat Freeman WR, Pichard AD, Smith H (1981) Effect of informed consent and educational background on patient knowledge, anxiety, and subjective responses to cardiac catheterization. Cathet Cardiovasc Diagn 7:119–134PubMedCrossRef Freeman WR, Pichard AD, Smith H (1981) Effect of informed consent and educational background on patient knowledge, anxiety, and subjective responses to cardiac catheterization. Cathet Cardiovasc Diagn 7:119–134PubMedCrossRef
Metadaten
Titel
Evaluation of a Method to Improve the Consent Process: Improved Data Retention with Stagnant Comprehension
verfasst von
Pranitha Naini
James Lewis
Kothanur Rajanna
Alva Bowen Weir III
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 1/2013
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-013-0453-5

Weitere Artikel der Ausgabe 1/2013

Journal of Cancer Education 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.